Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Aethlon Medical Inc.

    NASDAQ: AEMD · Real-Time Price · USD
    1.76
    -0.21 (-10.66%)
    At close: Jun 13, 2025, 3:59 PM
    1.78
    1.14%
    After-hours: Jun 13, 2025, 05:54 PM EDT

    Aethlon Medical Statistics

    Share Statistics

    Aethlon Medical has 2.01M shares outstanding. The number of shares has increased by 4.02% in one year.

    Shares Outstanding

    n/a
    		 2.01M

    Shares Change (YoY)

    n/a
    		 4.02%

    Shares Change (QoQ)

    n/a
    		 3.55%

    Owned by Institutions (%)

    n/a
    		 11.51%

    Shares Floating

    n/a
    		 1.89M

    Failed to Deliver (FTD) Shares

    n/a
    		 12,621

    FTD / Avg. Volume

    n/a
    		 50.11%

    Short Selling Information

    The latest short interest is 94.65K, so 0.59% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 94.65K

    Short % of Shares Out

    n/a
    		 0.59%

    Short % of Float

    n/a
    		 0.59%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.36 and the forward PE ratio is -3.52. Aethlon Medical's PEG ratio is 0.02.

    PE Ratio

    n/a
    		 -0.36

    Forward PE

    n/a
    		 -3.52

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0

    PB Ratio

    n/a
    		 0.75

    P/FCF Ratio

    n/a
    		 -0.42

    PEG Ratio

    n/a
    		 0.02
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Aethlon Medical.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.4, with a Debt / Equity ratio of 0.16.

    Current Ratio

    n/a
    		 3.4

    Quick Ratio

    n/a
    		 3.4

    Debt / Equity

    n/a
    		 0.16

    Debt / EBITDA

    n/a
    		 -0.08

    Debt / FCF

    n/a
    		 -0.09

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-872,000

    Employee Count

    n/a
    		 14

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 3

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -68.23% in the last 52 weeks. The beta is 1.88, so Aethlon Medical's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.88

    52-Week Price Change

    n/a
    		 -68.23%

    50-Day Moving Average

    n/a
    		 2.89

    200-Day Moving Average

    n/a
    		 3.62

    Relative Strength Index (RSI)

    n/a
    		 20.02

    Average Volume (20 Days)

    n/a
    		 25,187

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -359K

    Operating Income

    n/a
    		 -12.64M

    Net Income

    n/a
    		 -12.21M

    EBITDA

    n/a
    		 -11.85M

    EBIT

    n/a
    		 -12.21M

    Earnings Per Share (EPS)

    n/a
    		 -4.86
    Full Income Statement

    Balance Sheet

    The company has 5.44M in cash and 940.32K in debt, giving a net cash position of 4.5M.

    Cash & Cash Equivalents

    n/a
    		 5.44M

    Total Debt

    n/a
    		 940.32K

    Net Cash

    n/a
    		 4.5M

    Retained Earnings

    n/a
    		 -154.57M

    Total Assets

    n/a
    		 6.53M

    Working Capital

    n/a
    		 3.14M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -10.13M and capital expenditures -250.87K, giving a free cash flow of -10.38M.

    Operating Cash Flow

    n/a
    		 -10.13M

    Capital Expenditures

    n/a
    		 -250.87K

    Free Cash Flow

    n/a
    		 -10.38M

    FCF Per Share

    n/a
    		 -4.13
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    AEMD does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for AEMD is $56, which is 3081.8% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $56

    Price Target Difference

    n/a
    		 3081.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jun 9, 2025. It was a backward split with a ratio of 1:8.

    Last Split Date

    n/a
    		 Jun 9, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:8

    Scores

    Altman Z-Score

    n/a
    		 -34695.03

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist